THE USE OF EXPERT SURROGATES TO EVALUATE CLINICAL-TRIALS IN NON-SMALL CELL LUNG-CANCER

被引：70

作者：

MACKILLOP, WJ ^{[1
]}

WARD, GK ^{[1
]}

OSULLIVAN, B ^{[1
]}

机构：

[1] MCGILL UNIV,MCGILL CANC CTR,MONTREAL H3A 2T5,QUEBEC,CANADA

来源：

关键词：

D O I：

10.1038/bjc.1986.224

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：661 / 667

页数：7

共 14 条

[1] OBTAINING INFORMED CONSENT - FORM OR SUBSTANCE
EPSTEIN, LC
LASAGNA, L
[J]. ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (06) : 682 - &
[2] FOST NC, 1975, JAMA-J AM MED ASSOC, V223, P800
[3] INFORMED (BUT UNEDUCATED) CONSENT
INGELFINGER, FJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (09) : 465 - +
[4] JONAS H, 1969, DAEDALUS, V98, P219
[5] MACKILLOP WJ, 1985, J CHRONIC DIS, V39, P177
[6] MUSS HB, 1979, CANCER, V43, P1549, DOI 10.1002/1097-0142(197904)43:4<1549::AID-CNCR2820430449>3.0.CO
[7] 2-R
[8] PENMAN DT, 1984, J CLIN ONCOL, V2, P840
[9] INFORMED CONSENT - RECALL BY PATIENTS TESTED POSTOPERATIVELY
ROBINSON, G
MERAV, A
[J]. ANNALS OF THORACIC SURGERY, 1976, 22 (03) : 209 - 212
[10] SAURBREY N, 1984, ACTA MED SCAND, V215, P99